Improved meal-related beta-cell function and insulin sensitivity by the dipeptidyl peptidase-IV inhibitor vildagliptin in metformin-treated patients with type 2 diabetes over one year. - Ahrén,B.; Pacini,G.; Foley,JE.; Schweizer,A. (Diabetes Care, 2005)